Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank64
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P64
Within normal range
vs 2Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
20252.21%
2024-18.13%
20234.36%
2022-31.47%
202120.04%
2020-30.25%
2019-10.95%
2018-12.56%
2017-12.27%
2016-348.04%